These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 28487297)
1. MECHANISMS IN ENDOCRINOLOGY: Towards the clinical translation of stem cell therapy for type 1 diabetes. Espes D; Lau J; Carlsson PO Eur J Endocrinol; 2017 Oct; 177(4):R159-R168. PubMed ID: 28487297 [TBL] [Abstract][Full Text] [Related]
2. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges. Quiskamp N; Bruin JE; Kieffer TJ Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513 [TBL] [Abstract][Full Text] [Related]
3. Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells. Godfrey KJ; Mathew B; Bulman JC; Shah O; Clement S; Gallicano GI Diabet Med; 2012 Jan; 29(1):14-23. PubMed ID: 21883442 [TBL] [Abstract][Full Text] [Related]
4. Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet? Bourgeois S; Sawatani T; Van Mulders A; De Leu N; Heremans Y; Heimberg H; Cnop M; Staels W Cells; 2021 Jan; 10(1):. PubMed ID: 33477961 [TBL] [Abstract][Full Text] [Related]
5. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation. Bose B; Katikireddy KR; Shenoy PS Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920 [TBL] [Abstract][Full Text] [Related]
6. Pluripotent stem cell replacement approaches to treat type 1 diabetes. Pellegrini S; Piemonti L; Sordi V Curr Opin Pharmacol; 2018 Dec; 43():20-26. PubMed ID: 30071348 [TBL] [Abstract][Full Text] [Related]
7. Stem Cell-Based Therapies: A New Ray of Hope for Diabetic Patients. Khan J; Alexander A; Agrawal M; Ajazuddin ; Dubey SK; Siddique S; Saraf S; Saraf S Curr Stem Cell Res Ther; 2019; 14(2):146-151. PubMed ID: 30280677 [TBL] [Abstract][Full Text] [Related]
9. Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials. Senior PA; Pettus JH Diabet Med; 2019 Mar; 36(3):297-307. PubMed ID: 30362170 [TBL] [Abstract][Full Text] [Related]
10. Generating insulin-producing cells for diabetic therapy: existing strategies and new development. Shen J; Cheng Y; Han Q; Mu Y; Han W Ageing Res Rev; 2013 Mar; 12(2):469-78. PubMed ID: 23318683 [TBL] [Abstract][Full Text] [Related]
11. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus. Vanikar AV; Trivedi HL; Thakkar UG Cytotherapy; 2016 Sep; 18(9):1077-86. PubMed ID: 27424148 [TBL] [Abstract][Full Text] [Related]
12. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells. Yabe SG; Fukuda S; Takeda F; Nashiro K; Shimoda M; Okochi H J Diabetes; 2017 Feb; 9(2):168-179. PubMed ID: 27038181 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of Induced Pluripotent Stem Cell Therapies for Treatment of Type 1 Diabetes. Duffy C; Prugue C; Glew R; Smith T; Howell C; Choi G; Cook AD Tissue Eng Part B Rev; 2018 Dec; 24(6):482-492. PubMed ID: 29947303 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research. Hosokawa Y; Hanafusa T; Imagawa A J Diabetes Investig; 2019 Sep; 10(5):1158-1164. PubMed ID: 31161717 [TBL] [Abstract][Full Text] [Related]